WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

(Erstwhile WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth)

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 06-02-2024
Asset Class:
Benchmark: BSE Healthcare TRI
Expense Ratio: 2.38% As on (30-06-2025)
Status: Open Ended Schemes
Minimum Investment: 500.0
Minimum Topup: 500.0
Total Assets: 364.1 Cr As on (30-06-2025)
Turn over: -
NAV as on 22-07-2025

13.883

-0.05 (-0.3313%)

CAGR Since Inception

24.68%

BSE Healthcare TRI 15.08%

PERFORMANCE of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

Scheme Performance (%)

Data as on - 22-07-2025

Yearly Performance (%)

Fund Managers

Ramesh Mantri

Investment Objective

To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.

NAV & Lumpsum details( Invested amount 1,00,000)

Show All Monthly Lumpsum Returns
NAV Date NAV Units Market
Value
Returns
(%)
07-02-2024 10.072 9928.5147 100000 0.0 %
07-03-2024 9.944 - 98729 -1.27 %
08-04-2024 10.076 - 100040 0.04 %
07-05-2024 10.02 - 99484 -0.52 %
07-06-2024 10.337 - 102631 2.63 %
08-07-2024 10.889 - 108112 8.11 %
07-08-2024 11.703 - 116193 16.19 %
09-09-2024 12.724 - 126330 26.33 %
07-10-2024 12.732 - 126410 26.41 %
07-11-2024 13.183 - 130888 30.89 %
09-12-2024 13.403 - 133072 33.07 %
07-01-2025 13.876 - 137768 37.77 %
07-02-2025 13.301 - 132059 32.06 %
07-03-2025 12.154 - 120671 20.67 %
07-04-2025 11.933 - 118477 18.48 %
07-05-2025 12.807 - 127154 27.15 %
09-06-2025 13.194 - 130997 31.0 %
07-07-2025 13.715 - 136170 36.17 %
22-07-2025 13.883 - 137838 37.84 %

RETURNS CALCULATOR for WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

riskometer

Key Performance and Risk Statistics of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth - - - - - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

Amount :
Start :
End :
Period
Data as on - 22-07-2025
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 06-02-2024 26.09 0.0 0.0 0.0 0.0
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 27.03 0.0 0.0 0.0 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 20.56 27.28 27.88 24.09 11.9
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 19.37 33.18 28.69 24.29 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 18.49 31.0 25.96 22.02 11.75
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 15.19 27.11 20.73 17.39 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 14.07 26.69 25.09 22.67 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 13.84 27.16 22.91 22.06 0.0
Kotak Healthcare Fund - Regular Plan - Growth Option 11-12-2023 13.34 0.0 0.0 0.0 0.0
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 12.14 25.1 22.31 0.0 0.0

PORTFOLIO ANALYSIS of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

Asset Allocation (%)

Allocation Percentage (%)

Market Cap Distribution

Small Cap

36.42%

Others

7.55%

Large Cap

37.65%

Mid Cap

18.38%

Total

100%